CS0240-0600 program

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameCS0240-0600 program
Drug Alias NameHDAC inhibitors (Shenzhen Chipscreen Biosciences)CS-0240CS-0600
ClassificationSmall molecules
Mechanisms of ActionHistone deacetylase inhibitorsNeuroprotectantsImmunomodulators
TargetsHistone deacetylase
Therapy Area/IndicationsNerve DegenerationImmune System DiseasesVirus Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaPending
Originator CompaniesShenzhen Chipscreen Biosciences Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesShenzhen Chipscreen Biosciences Co Ltd
Active IndicationsN/A
Inactive IndicationsNerve DegenerationImmune System DiseasesVirus Diseases

Other Information

ATC CodeN/A
Related LinksN/A